Qiangwei Liang

421 total citations
11 papers, 328 citations indexed

About

Qiangwei Liang is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Qiangwei Liang has authored 11 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Immunology and 5 papers in Biomedical Engineering. Recurrent topics in Qiangwei Liang's work include Nanoplatforms for cancer theranostics (5 papers), Immune cells in cancer (4 papers) and Liver physiology and pathology (2 papers). Qiangwei Liang is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Immune cells in cancer (4 papers) and Liver physiology and pathology (2 papers). Qiangwei Liang collaborates with scholars based in China. Qiangwei Liang's co-authors include Yanhua Liu, Jinxia Liu, Yifan Li, Jiayu Yang, Juan Li, Yue Sun, Lan Yang, Lan Yang, Lu Liu and Lu Liu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Acta Biomaterialia and European Journal of Pharmaceutics and Biopharmaceutics.

In The Last Decade

Qiangwei Liang

11 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qiangwei Liang China 8 117 108 92 71 64 11 328
Yunzhen Gao China 12 91 0.8× 206 1.9× 107 1.2× 68 1.0× 42 0.7× 18 436
Bingqiang Gao China 10 97 0.8× 137 1.3× 64 0.7× 69 1.0× 44 0.7× 21 401
Hong Jin China 8 78 0.7× 186 1.7× 66 0.7× 39 0.5× 41 0.6× 13 333
Xiaopeng Guo China 11 83 0.7× 82 0.8× 58 0.6× 45 0.6× 39 0.6× 31 337
Marta Benito Spain 13 72 0.6× 126 1.2× 160 1.7× 84 1.2× 92 1.4× 20 462
Xiaoqin Jia China 12 93 0.8× 165 1.5× 117 1.3× 45 0.6× 58 0.9× 29 411
Yuesong Wu China 8 117 1.0× 121 1.1× 74 0.8× 33 0.5× 103 1.6× 20 320
Sun Hwa Kim South Korea 10 71 0.6× 128 1.2× 171 1.9× 164 2.3× 52 0.8× 25 453

Countries citing papers authored by Qiangwei Liang

Since Specialization
Citations

This map shows the geographic impact of Qiangwei Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qiangwei Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qiangwei Liang more than expected).

Fields of papers citing papers by Qiangwei Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qiangwei Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qiangwei Liang. The network helps show where Qiangwei Liang may publish in the future.

Co-authorship network of co-authors of Qiangwei Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Qiangwei Liang. A scholar is included among the top collaborators of Qiangwei Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qiangwei Liang. Qiangwei Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Liu, Zihan, et al.. (2024). Albumin nanoassembly bi-directionally manipulated ferroptosis in tumor and CD8+ T cells for triple-negative breast cancer therapy. Asian Journal of Pharmaceutical Sciences. 20(2). 100970–100970. 5 indexed citations
2.
Zhang, Xiaojie, Qiangwei Liang, Min An, et al.. (2024). Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy. Journal of Nanobiotechnology. 22(1). 319–319. 13 indexed citations
3.
Li, Juan, Qiangwei Liang, Jiayu Yang, et al.. (2023). Tumor Microenvironment Sequential Drug/Gene Delivery Nanosystem for Realizing Multistage Boosting of Cancer–Immunity Cycle on Cancer Immunotherapy. ACS Applied Materials & Interfaces. 15(47). 54898–54914. 6 indexed citations
4.
5.
Liang, Qiangwei, Yifan Li, Juan Li, et al.. (2022). Collagenase-I decorated co-delivery micelles potentiate extracellular matrix degradation and hepatic stellate cell targeting for liver fibrosis therapy. Acta Biomaterialia. 152. 235–254. 31 indexed citations
6.
Li, Yifan, et al.. (2022). Metal nanoparticles: a platform integrating diagnosis and therapy for rheumatoid arthritis. Journal of Nanoparticle Research. 24(4). 13 indexed citations
7.
Liang, Qiangwei, et al.. (2022). Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy. European Journal of Pharmaceutics and Biopharmaceutics. 177. 260–272. 21 indexed citations
8.
Liang, Qiangwei, et al.. (2022). The therapeutic efficacy and safety improvements of crizotinib prodrug micelles on breast cancer treatment. Pharmaceutical Development and Technology. 27(4). 469–478. 2 indexed citations
9.
Liang, Qiangwei, et al.. (2021). Nano drug delivery system reconstruct tumour vasculature for the tumour vascular normalisation. Journal of drug targeting. 30(2). 119–130. 34 indexed citations
10.
11.
Yang, Lan, Qiangwei Liang, Yue Sun, et al.. (2020). Codelivered Chemotherapeutic Doxorubicin via a Dual-Functional Immunostimulatory Polymeric Prodrug for Breast Cancer Immunochemotherapy. ACS Applied Materials & Interfaces. 12(28). 31904–31921. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yunzhen Gao Breakdown of academic impact, for papers by Bingqiang Gao Breakdown of academic impact, for papers by Hong Jin Breakdown of academic impact, for papers by Xiaopeng Guo Breakdown of academic impact, for papers by Marta Benito Breakdown of academic impact, for papers by Xiaoqin Jia Breakdown of academic impact, for papers by Yuesong Wu Breakdown of academic impact, for papers by Sun Hwa Kim
Rankless by CCL
2026